Information Technology·Semiconductor Materials & Equipment·$3.0B
AEHR Test Systems operates in the semiconductor materials and equipment sector, focusing on providing testing solutions for semiconductor manufacturers. As the demand for advanced semiconductor technology grows, especially with trends like AI and cloud computing, AEHR's role becomes increasingly important in ensuring product quality and reliability.
EPS
Earnings per share is a key indicator of profitability and will help gauge the company's financial health this quarter.
Revenue
While specific revenue estimates are not available, any reported revenue will be crucial for understanding overall business performance.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
8Q
EPS Beat Rate
100%
Avg EPS Surprise
+315.33%
Avg Stock Reaction
-1.34%
In Q3 2026, AEHR reported an EPS of -$0.05, outperforming expectations by 64.29%. However, the stock declined by 3.66% the following day, indicating mixed market reactions.
Management Promises & Guidance
Investors are cautiously optimistic ahead of AEHR's earnings report, given the company's history of beating EPS estimates. However, the lack of revenue guidance adds uncertainty.
Bull Case
If AEHR continues its trend of beating EPS estimates, it could signal strong operational performance and market demand, potentially leading to a positive stock reaction.
Bear Case
Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about its growth prospects in a competitive semiconductor market.
EPS
N/AEarnings per share is a key indicator of profitability and will help gauge the company's financial health this quarter.
Revenue
N/AWhile specific revenue estimates are not available, any reported revenue will be crucial for understanding overall business performance.
The print will turn on these two things.
Q1
What is the company's projected revenue growth for the upcoming quarter?
Revenue growth will be a critical indicator of AEHR's market position and demand for its testing solutions.
Q2
How is AEHR addressing supply chain challenges in the semiconductor industry?
Supply chain issues have been a significant concern in the semiconductor sector, and AEHR's response will impact its operational efficiency and customer satisfaction.
Why consensus could be wrong
The Street may underestimate AEHR's ability to capitalize on emerging semiconductor trends, particularly in AI and cloud applications, which could drive unexpected revenue growth.
Supporting Evidence
AEHR has consistently beaten EPS estimates, indicating stronger-than-expected performance.
The semiconductor market is experiencing increased demand, which could benefit AEHR more than anticipated.
Recent trends in AI and cloud computing suggest a growing need for advanced testing solutions.
Key Risk
If AEHR reports significant revenue growth driven by new contracts, it could challenge the current consensus outlook.
Pre-commit to what would confirm each case.
This quarter's performance will hinge on AEHR's ability to demonstrate growth amidst a challenging semiconductor landscape.
Bull Confirmed If
A revenue growth rate of at least 15% year-over-year would confirm the bull case, indicating strong demand for AEHR's products.
Bear Confirmed If
If revenue growth is flat or negative, it would support the bear case, raising concerns about market competitiveness.
Implied Move
±N/A
Historical Avg
±3.2%
There is no options market data available to assess implied volatility or expected price movement.
Options are pricing ±72.7% while AEHR has averaged ±3.2% over the last 8 prints — setup is pricing rich.
Likely market behavior by outcome — not investment advice.
Beat & Raise
If AEHR beats expectations and raises guidance, history suggests a potential average stock move of +2.03%, confirming strong operational performance.
In-Line / Cautious
If results are in line with expectations but management provides cautious commentary, the stock may react neutrally, reflecting uncertainty.
Miss
Should AEHR miss expectations, history suggests an average decline of -1.34%, indicating market disappointment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
GOLDMAN SACHS GROUP
Jul 14, 2026